Regulations

(Eoneren/iStock via Getty Images Plus)

Recent FDA COVID-19 actions and updates

By Jenni Spinner

The US agency continues to oversee vaccine and drug development, and to share information and advice for life-sciences professionals and civilians alike.

(alengo/iStock via Getty Images Plus)

People on the Move: September 2021

By Jenni Spinner

This month’s news on new hires, board launches, acquisitions, and other important news includes items on Pfizer, Javara, Clinical Ink, and other companies.

(Jonathan Kitchen/iStock via Getty Images Plus)

Latest COVID-19 updates from the FDA

By Jenni Spinner

The US Food and Drug Administration continues to review potential preventatives and treatments for the virus, and to offer advice to life-sciences professionals and civilians alike.

(Thaweesak Saengngoen/iStock via Getty Images Plus)

Recent FDA COVID-19 actions and updates

By Jenni Spinner

The agency has been busy with actions related to the virus behind the pandemic, keeping an eye on vaccinations, emerging variants, and other concerns.

(Who_I_am/iStock via Getty Images Plus)

Tech Innovations: June 2021

By Jenni Spinner

This month’s roundup of new equipment, materials, tech partnerships and other news includes items from Ajinomoto, Evonik, Quanticate, Pharmasol, and more.

© GettyImages/Pheelings Media

FDA rebuff for Keytruda in breast cancer indication

By Jane Byrne

A couple of new developments to report in relation to Merck, known as MSD outside the US and Canada: the first being the rejection by the US FDA of the company’s application to use its anti-PD-1 therapy, Keytruda, in certain breast cancer patients.

Follow us

Product Innovations

Multiple Sclerosis Analytical Report

Multiple Sclerosis Analytical Report

More than 2.3 million people are living with MS worldwide. Although there is no cure, new research and innovative treatments are continuously emerging....